Russell Investments Group
CGEM icon

Russell Investments Group’s Cullinan Oncology CGEM Stock Holding History

Russell Investments Group’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$521K Buy
28,584
+24,312
+569% +$361K ﹤0.01% 2755
2026
Q1 		$60.7K Sell
4,272
-20,137
-82% -$259K ﹤0.01% 3259
2025
Q4 		$253K Buy
24,409
+20,137
+471% +$182K ﹤0.01% 2754
2025
Q3 		$25.3K Sell
4,272
-36,714
-90% -$269K ﹤0.01% 3526
2025
Q2 		$309K Buy
40,986
+11,623
+40% +$93.4K ﹤0.01% 2511
2025
Q1 		$222K Buy
+29,363
New +$282K ﹤0.01% 2561
2024
Q3 		– Sell
-34,293
Closed -$598K – 3706
2024
Q2 		$598K Buy
+34,293
New +$730K ﹤0.01% 2140
2024
Q1 		– Sell
-2,300
Closed -$23.4K – 3314
2023
Q4 		$23.4K Buy
+2,300
New +$20.4K ﹤0.01% 2726
2023
Q3 		– Sell
-21,784
Closed -$234K – 3539
2023
Q2 		$234K Buy
21,784
+19,598
+897% +$208K ﹤0.01% 2438
2023
Q1 		$22.4K Buy
+2,186
New +$24.1K ﹤0.01% 2800

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Russell Investments Group's CGEM Position: Q2 2026 in Review

Russell Investments Group increased its Cullinan Oncology (CGEM) stake by 569% in Q2 2026, buying an estimated $361K and bringing the position to 28,584 shares worth $521K. The position accounts for ﹤0.01% of the portfolio, ranked #2755.

Russell Investments Group first reported a position in CGEM in Q1 2023 and has held it in 10 quarters since. The position peaked at $598K in Q2 2024. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Russell Investments Group held 28,584 shares of Cullinan Oncology worth $521K as of Q2 2026.
  • Russell Investments Group bought 24,312 Cullinan Oncology shares in Q2 2026, an estimated $361K.
  • Cullinan Oncology made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2755 holding.
  • Russell Investments Group first reported a position in Cullinan Oncology in Q1 2023 and has held it in 10 quarters since.
  • Russell Investments Group's Cullinan Oncology position peaked at $598K in Q2 2024.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.